Dhananjay Sathe (@d_sathe) header
Dhananjay Sathe (@d_sathe) profile picture

software overlord @RapyutaRobotics, shitpost, dive and travel off the grid when possible

Bengaluru, India
Joined June 2009
Photo by Dhananjay Sathe (@d_sathe)Photo by Dhananjay Sathe (@d_sathe)Photo by Dhananjay Sathe (@d_sathe)Photo by Dhananjay Sathe (@d_sathe)Photo by Dhananjay Sathe (@d_sathe)Photo by Dhananjay Sathe (@d_sathe)Photo by Dhananjay Sathe (@d_sathe)Photo by Dhananjay Sathe (@d_sathe)Photo by Dhananjay Sathe (@d_sathe)Photo by Dhananjay Sathe (@d_sathe)
Dhananjay Sathe retweeted
Remember when Bloomberg literally ran the headline: "China's curing cancer faster and cheaper than anywhere else. But some worry they may be going too fast"? Now look at how the Financial Times is framing this new FDA decision: "FDA rejects cancer drug invented in China in blow to Beijing's biotech sector." A "blow to Beijing"? Chinese lung cancer patients ALREADY have this drug. Not only is it approved across China, it is covered by public health insurance, where a single vial costs roughly $100 USD (around $1,300 per treatment cycle before insurance even kicks in to cover most of the bill). Meanwhile, in separate head-to-head trials, this exact Chinese drug beat Merck's Keytruda, which is Big Pharma's $30 billion-a-year cash cow and the best-selling cancer drug on earth. In the U.S., Keytruda carries a list price of over $12,500 per three-week dose, adding up to more than $200,000 a year. So why did the FDA block this initial U.S. application? While a larger global trial is still wrapping up, the U.S. partner company applied first to use the drug for a smaller, harder-to-treat group of lung cancer patients whose previous treatments had failed. Even though the drug clearly slowed down tumor growth, the FDA rejected it, claiming that slowing tumors wasn't enough without stronger long-term survival proof and complaining that too many patients in the trial were Chinese. Here is the kicker: a Harvard Medical School study found that over half (57%) of the cancer drugs fast-tracked onto the market by the FDA failed to prove within five years that they actually helped patients live longer or feel better. For years, the FDA happily let Western pharma giants charge Americans $200,000 a year for drugs that only slowed or shrank tumors on paper. Yet the moment a superior Chinese drug threatens Big Pharma's biggest monopoly and exposes what cancer treatment actually costs outside the U.S. pricing racket, the FDA suddenly discovers "strict standards." Even if you take the FDA's red tape at face value, look at the media sickness on display. Western outlets are cheering a blocked lung cancer treatment like it is a geopolitical scoreboard win over China, when the only people being denied the option right now are Americans. Imagine framing American cancer patients having fewer options while still paying $200,000 a year as "owning Beijing."
121
2,163
96
8,505
257,703
Dhananjay Sathe retweeted
Jensen Huang, what’s his net worth ?
2
8
225
Tweet of the week
Between Microsoft and the FAA, it's a bad time to be a copilot
56
Dhananjay Sathe retweeted
Everyone is all against alcohol and sugar now. But who was there when your life was falling apart? It sure wasn’t fucking salad.
641
10,722
711
80,569
2,653,517
Dhananjay Sathe retweeted
just randomly remembered y'all were buying & selling JPEGs for thousands of dollars (and were, like, super serious about it) just 4 years ago
120
275
34
3,988
104,400
At this point normal typing experience and UX is the key differentiator for voice typing keyboards. The models are all the same but there are many, many circumstances in which you can't use voice typing and you have to use the keyboard.
34
Dhananjay Sathe retweeted
A good reminder that just because you cuda doesn’t mean you shuda.
38
217
24
2,779
79,942
Dhananjay Sathe retweeted
This is a good filter for people who I don’t want to work with. Please understand how computers work. This isn’t even about understanding Docker. Any software person should know how the layers work at a high level and this is a VERYYYYY high level.
A surprising amount of people don't know that Docker on macOS is actually a VM
192
176
46
5,794
519,436
Dhananjay Sathe retweeted
Nvidia stock fell 12% because of election and another 10% because of erection
1,008
11,466
1,612
131,883
6,995,332
Dhananjay Sathe retweeted
the most import skill in 2026 is still being able to tell your agents "wtf is this crap, no, not like this" if you stop doing that, you're basically fucked, despite what some devfluencers would like you to think.
209
415
84
4,207
209,567
Dhananjay Sathe retweeted
amazon workers pee in bottles to hit their quota on time microsoft does another round of layoffs to cut opex and pump the stock google does the same so the ceo can earn his stock based comp chamath, the spac sellor, is now the voice of the American middle class elon spends half a billion on elections, then wants to give every kid his stock. someone has to be the exit liquidity but don’t worry. any day now, every ceo will look up and say: friends, the stock has pumped enough. we have earned enough. let us share the ai dividend. and we’ll all hold hands, and dance, and enjoy the fruits of agi.
7
1
106
6,892
Dhananjay Sathe retweeted
Using a stick of RAM to stir my coffee this morning, fuck you, Sam Altman
570
11,052
257
183,629
2,768,745
Dhananjay Sathe retweeted
Today we're launching Dollars 💰 Most AI startups spend so much time and effort building an AI product with negative gross margins. We skipped straight to the end. We sell US dollar bills for $0.80. TAM: $1T+ in circulation. We’re going after all of it. Let’s scale to the moon together. dollars for less dot com
194
94
88
2,822
998,871
Dhananjay Sathe retweeted
The sort of thing your agent writes tests for
The chances of being killed by a landmine delivered by a bear are low, but they are never zero.
77
836
36
14,207
328,609
Dhananjay Sathe retweeted
Just one more Gemini CTA, bro. That’ll fix it.
Anthropic: We have the best model. Google:
8
25
1
515
18,990
Dhananjay Sathe retweeted
very weird thing happening rn technical people are sad, they think their skills are now useless non-technical people are desperately wishing they were more technical so they could use agents better
1,553
2,410
683
36,896
1,980,430
Dhananjay Sathe retweeted
I would too if I used Co-Pilot.
Bill Gates predicts a massive number of people will reject AI and choose to "live like the Amish."
296
1,078
81
23,103
557,216
💯
I see how some people can watch flashy robot demos on the timeline and think with a shiver that the robot apocalypse is around the corner, but reality check: There is no robot in the world that can change the batteries in a jack-o-lantern. If you have a robot friendly door handle it might be able to walk outside, pick it up, and carry it back inside. The robot could open the drawer with your batteries in it, but then things get tough. Opening the package of AA batteries? Extracting a precision screwdriver from its case? Unscrewing four tiny screws that require a hard press and twist? Popping batteries out of the case? Yes, you could build and train a specialist robot to do that today, but there is a very long way to go to replace the full range of human capabilities. Near term doomer scenarios should stop at “secretly controlling humanity” instead of “wiping humanity out” 😀
64
Dhananjay Sathe retweeted
Made them use Jira
JUST IN: Japanese scientists force cancer cells to kill themselves in new experiments
96
848
40
19,937
550,342
Dhananjay Sathe retweeted
Person who is reverse engineering his tv gets banned from OpenAI You aren't allowed to stop your tv from spying on your family. You have to ask for permission Or, maybe, maybe we accelerate
banned for reverse engineering work? that’s wild oh well, -$500, and a bunch of banked resets) but gained motivation to get 3 more machines and finish my cluster. i have never used openai to exploit or find vulnerabilities, only local reverse engineering which tripped daybreak.
288
2,149
97
27,316
883,389